Kymriah (tisagen lecleucel) cancer medication
Ended Awarded Last action
- Contract number
- 36C25720F0196
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $283,527
Award facts
- Contract value 100% obligated
- $283,526.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Temple, TX 76504, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order to Novartis Pharmaceuticals Corp., doing business as NPS, for the specialized cancer medication KYMRIAH (TISAGENLECLEUCEL). The $283,526.57 firm fixed price order was placed against Novartis' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which has a total potential value of $5.4 billion and extends through August 2025. Novartis, a foreign-owned for-profit manufacturer, has provided KYMRIAH and other specialty drug products to support VA medical programs across the country. The VA has also awarded Novartis a $21.5 million blanket purchase agreement against the pharmaceutical schedule to facilitate continued orders for KYMRIAH through September 2024. This contract award did not have a set-aside designation.
Quick answers
Who was awarded contract 36C25720F0196?
36C25720F0196 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 17 (Veterans Health Administration) on April 3, 2020.
How much is contract 36C25720F0196 worth?
The government has obligated $283,527 on 36C25720F0196.
Is contract 36C25720F0196 an order under another contract?
Yes. 36C25720F0196 is a delivery order under V797D30268, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25720F0196 competed?
The extent of competition for 36C25720F0196 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award